Have a feature idea you'd love to see implemented?
Let us know!
SHPH Shuttle Pharmaceuticals Holdings Inc
Price (delayed)
$0.882
Market cap
$3.23M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.19
Enterprise value
$3.64M
Highlights
The debt has shrunk by 51% QoQ and by 42% YoY
Shuttle Pharmaceuticals Holdings's EPS has increased by 29% YoY but it has decreased by 19% from the previous quarter
Shuttle Pharmaceuticals Holdings's equity has shrunk by 123% YoY
The company's quick ratio has shrunk by 99% YoY and by 95% QoQ
Key stats
What are the main financial stats of SHPH
Market
Valuations
Earnings
Shares outstanding
3.66M
Market cap
$3.23M
Enterprise value
$3.64M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$7.45M
EBITDA
-$7.45M
Free cash flow
-$5.7M
Per share
Balance sheet
Liquidity
EPS
-$4.19
Free cash flow per share
-$2.39
Book value per share
-$0.59
Revenue per share
$0
TBVPS
$0.28
Total assets
$673,568
Total liabilities
$1.99M
Debt
$564,257
Equity
-$1.32M
Working capital
-$1.3M
Debt to equity
-0.43
Current ratio
0.22
Quick ratio
0.09
Net debt/EBITDA
-0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-258.9%
Return on equity
-583%
Return on invested capital
-378.3%
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SHPH stock price
How has the Shuttle Pharmaceuticals Holdings stock price performed over time
Intraday
-1.78%
1 week
-17.57%
1 month
-31.63%
1 year
-77.84%
YTD
-75.77%
QTD
-33.68%
Financial performance
How have Shuttle Pharmaceuticals Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.2M
Net income
-$9.19M
Gross margin
N/A
Net margin
N/A
Shuttle Pharmaceuticals Holdings's operating income has decreased by 40% YoY and by 25% QoQ
The net income has declined by 28% since the previous quarter and by 20% year-on-year
Growth
What is Shuttle Pharmaceuticals Holdings's growth rate over time
Valuation
What is Shuttle Pharmaceuticals Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Shuttle Pharmaceuticals Holdings's EPS has increased by 29% YoY but it has decreased by 19% from the previous quarter
Shuttle Pharmaceuticals Holdings's equity has shrunk by 123% YoY
Efficiency
How efficient is Shuttle Pharmaceuticals Holdings business performance
SHPH's return on equity has dropped by 168% since the previous quarter
The ROA has shrunk by 144% YoY and by 88% QoQ
The company's return on invested capital has shrunk by 124% QoQ and by 64% YoY
Dividends
What is SHPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SHPH.
Financial health
How did Shuttle Pharmaceuticals Holdings financials performed over time
SHPH's total assets is 66% smaller than its total liabilities
The company's quick ratio has shrunk by 99% YoY and by 95% QoQ
Shuttle Pharmaceuticals Holdings's current ratio has shrunk by 97% YoY and by 88% QoQ
The debt is 143% higher than the equity
The company's debt to equity has shrunk by 130% QoQ
Shuttle Pharmaceuticals Holdings's equity has shrunk by 123% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.